The apparently contradictory results of the aforementioned studies may stem from uncontrolled variables related to disease complications, such as polycystic ovary syndrome and MetS, that themselves can regulate betatrophin levels in obese people [31,32,33]. Here, ANGPTL8 is linked to metabolic syndrome.